This preview shows page 1. Sign up to view the full content.
Unformatted text preview: e’s words, ‘‘you don’t know if either of them worked’’ (Vastag 2000:2984). By contrast, a placebo-control trial is capable of showing difference, and, much more importantly, it is able to discern effective and ineffective treatments. Such ability is considered a key marker of reliable evidence of the effectiveness of a new drug. Active-control trials fail to make such a distinction and are therefore not preferable from a regulatory standpoint. A certain kind of global human subject is at stake in Temple’s description of failure of active-control trials. Most people in low-income countries, those places where many clinical trials are heading, are subject to the external factors that are said to lead to the study defects cited above. They may have medical histories that are patchy at best, thus making cross-cultural interpretation of the meaning of drug effectiveness less reliable. Their diagnoses can be inconsistent, also confusing evidence on drug effectiveness. Not only is quali...
View Full Document
This note was uploaded on 10/10/2010 for the course ENG 000121 taught by Professor Mcgrand during the Spring '10 term at Cornell.
- Spring '10